BIT
CLVS

BlackRock Institutional Trust’s Clovis Oncology, Inc. CLVS Stock Holding History

BlackRock Institutional Trust’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$40.5M Buy
912,651
+58,137
+7% +$2.05M 0.01% 1475
2016
Q3 		$30.8M Buy
854,514
+31,478
+4% +$675K ﹤0.01% 1593
2016
Q2 		$11.3M Sell
823,036
-2,049
-0.2% -$30K ﹤0.01% 2215
2016
Q1 		$15.8M Buy
825,085
+54,476
+7% +$1.15M ﹤0.01% 1966
2015
Q4 		$27M Buy
770,609
+14,029
+2% +$905K ﹤0.01% 1643
2015
Q3 		$69.6M Buy
756,580
+65,779
+10% +$5.69M 0.01% 1040
2015
Q2 		$60.7M Sell
690,801
-28,821
-4% -$2.47M 0.01% 1193
2015
Q1 		$53.4M Buy
719,622
+3,902
+0.5% +$276K 0.01% 1278
2014
Q4 		$40.1M Sell
715,720
-30,796
-4% -$1.62M 0.01% 1442
2014
Q3 		$33.9M Sell
746,516
-18,217
-2% -$761K 0.01% 1528
2014
Q2 		$31.7M Sell
764,733
-179,237
-19% -$9.23M 0.01% 1637
2014
Q1 		$65.4M Buy
943,970
+300,508
+47% +$22.1M 0.01% 1118
2013
Q4 		$38.8M Buy
643,462
+221,458
+52% +$12M 0.01% 1457
2013
Q3 		$25.7M Buy
422,004
+155,870
+59% +$11.1M 0.01% 1673
2013
Q2 		$17.8M Buy
+266,134
New +$12M ﹤0.01% 1888

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock Institutional Trust's CLVS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Clovis Oncology, Inc. (CLVS) stake by 6.8% in Q4 2016, buying an estimated $2.05M and bringing the position to 912,651 shares worth $40.5M. The position accounts for 0.01% of the portfolio, ranked #1475.

BlackRock Institutional Trust first reported a position in CLVS in Q2 2013 and has held it in 15 quarters since. The position peaked at $69.6M in Q3 2015. 167 funds tracked by Wall St. Rank hold CLVS as of Q4 2016.

  • BlackRock Institutional Trust held 912,651 shares of Clovis Oncology, Inc. worth $40.5M as of Q4 2016.
  • BlackRock Institutional Trust bought 58,137 Clovis Oncology, Inc. shares in Q4 2016, an estimated $2.05M.
  • Clovis Oncology, Inc. made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1475 holding.
  • BlackRock Institutional Trust first reported a position in Clovis Oncology, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Institutional Trust's Clovis Oncology, Inc. position peaked at $69.6M in Q3 2015.
  • 167 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.